Morgan Stanley assumed coverage on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report published on Friday, ...
The corporate regulator has been asking questions related to Sidara’s $1.4 billion sale of Worley stock last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback